Primary-care-provider Identification And Notification

计划入组 7,023 人 · 首次发布于 2013 年 11 月 15 日

Hospital Outcomes: Intervention in Moderately III Patients

计划入组 444 人 · 首次发布于 2005 年 11 月 21 日

Nantou Hospital, Regional Teaching Hospital

计划入组 150 人 · 首次发布于 2021 年 1 月 6 日

LC106(Massachusetts General Hospital)

anti-CXCR4 mRNA vaccine (Massachusetts General Hospital/Brigham and Women’s Hospital)

EBV-Tscm Cytotoxic T Cells(University Hospital, Basel)

New York Presbyterian Hospital \ Weill Cornell University Medical Center

United States

NEWYORK-PRESBYTERIAN/QUEENS

United States

New York Presbyterian Hospital

United States

Liquid Biopsy Advances Transform MRD Detection in High-Risk Breast Cancer Management

Selinexor Shows Promise as Affordable Myelofibrosis Treatment Option

EMPOWER CAD Study Confirms Benefits of IVL-First Strategy in Female Patients with Calcified Coronary Lesions